This event has ended. Visit the official site or create your own event on Sched.


David Robinson

Robinson Vaccines and Biologics LLC
Principal Consultant
Independent consultant with 25 years experience in global vaccine and biologics product commercialization, process development and CMC regulatory strategy/execution (IND, BLA, PAS). Over 20 years at Merck, chaired the CMC development team that achieved approval of RotaTeq, an oral live virus vaccine, headed the product development teams that entered Merck’s first biosimilars into development and led the CMC regulatory group that achieved approval of the first anti-PD1 oncology mab, Keytruda.